Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Prelude Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PRLD.
You can purchase shares of Prelude Therapeutics (NASDAQ:PRLD) through any online brokerage.
Other companies in Prelude Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Skye Bioscience (NASDAQ:SKYE), Fortress Biotech (NASDAQ:FBIO) and Adverum Biotechnologies (NASDAQ:ADVM).
Prelude Therapeutics has a consensus price target of $5.29.
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $1.09 last updated June 13, 2025 at 8:46 AM EDT.
There are no upcoming dividends for Prelude Therapeutics.
Prelude Therapeutics’s Q2 earnings are confirmed for Monday, August 11, 2025.
There is no upcoming split for Prelude Therapeutics.
Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.